Patents by Inventor Brooks M. Hybertson

Brooks M. Hybertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrochemical plasma activated aqueous chemo therapeutics
    Patent number: 11666652
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: June 6, 2023
    Assignee: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
    Publication number: 20200323982
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 15, 2020
    Applicant: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • Electrochemical plasma activated aqueous chemotherapeutics
    Patent number: 10610590
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: April 7, 2020
    Assignee: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
    Publication number: 20170312362
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Application
    Filed: May 2, 2017
    Publication date: November 2, 2017
    Applicant: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • Plasminogen activator as an anti-inflammatory agent
    Patent number: 6497877
    Abstract: Plasminogen activator acts as an anti-inflammatory agent by inhibiting generation of superoxide anion by a mechanism that is not related to L-arginine, is not dependent on thrombolytic activity, and is not a function of oxygen free radical scavenging. Moreover, in in vivo models of inflammation, treatment with plasminogen activator reduces edema without inhibiting neutrophil infiltration in in vivo models of inflammation.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: December 24, 2002
    Assignee: University Technology Corporation
    Inventors: Kathleen A. Stringer, Brooks M. Hybertson, John E. Repine, Joe M. McCord
  • Methods and apparatus for drug delivery using supercritical solutions
    Patent number: 5301664
    Abstract: Methods and apparatus for delivering physiologically active compounds to a target human or animal employ a supercritical fluid solution comprising a supercritical fluid solvent and a physiologically active solute. The supercritical fluid solution is passed into a subcritical region to evaporate the solvent and form a gas-borne dispersion of solute particles. The gas-borne dispersion of solute particles is administered directly to the target human or animal. The apparatus for delivering the physiologically active compound are of the hand-held type.
    Type: Grant
    Filed: March 6, 1992
    Date of Patent: April 12, 1994
    Inventors: Robert E. Sievers, Brooks M. Hybertson, Brian N. Hansen